We are live on ! Find out more
JUNO

Juno Therapeutics, Inc.
JUNO

Delisted

JUNO was delisted on the 5th of March, 2018.

Back to rankings

157 hedge funds and large institutions have $1.55B invested in Juno Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 52 increasing their positions, 48 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more capital invested

Capital invested by funds: $1.27B → $1.55B (+$281M)

12% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 26

8% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 48

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

1% less funds holding

Funds holding: 159 → 157 (-2)

26% less call options, than puts

Call options by funds: $13.1M | Put options by funds: $17.7M

Holders
157
Holders Change
-2
Holders Change %
-1.26%
% of All Funds
3.91%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
29
Increased
52
Reduced
48
Closed
26
Calls
$13.1M
Puts
$17.7M
Net Calls
-$4.61M
Net Calls Change
+$3.68M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$89.5M
2
Norges Bank
Norges Bank
Norway
+$17.9M
3
ACH
ArrowMark Colorado Holdings
Colorado
+$15.9M
4
Goldman Sachs
Goldman Sachs
New York
+$15.3M
5
CAM
Cormorant Asset Management
Massachusetts
+$13.9M

Top Sellers

Rank Fund Capital Flow
1
SCM
Scopia Capital Management
New York
-$33.5M
2
State Street
State Street
Massachusetts
-$8.62M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$4.42M
4
AQR Capital Management
AQR Capital Management
Connecticut
-$3.76M
5
Citigroup
Citigroup
New York
-$3.64M
Name Holding Trade Value Shares
Change 		Change in
Stake
AA
51
ALPS Advisors
Colorado
$2.02M -$229K -10,659 -10%
EAM
52
Eventide Asset Management
Massachusetts
$2M – – –
Point72 Asset Management
53
Point72 Asset Management
Connecticut
$1.95M +$1.89M +87,900 New
Citigroup
54
Citigroup
New York
$1.94M -$3.64M -169,544 -66%
California Public Employees Retirement System
55
California Public Employees Retirement System
California
$1.58M -$66.5K -3,100 -4%
RhumbLine Advisers
56
RhumbLine Advisers
Massachusetts
$1.54M +$82.6K +3,853 +6%
UBS Group
57
UBS Group
Switzerland
$1.53M -$2.55M -119,011 -63%
CS
58
Candriam SCA
Luxembourg
$1.53M -$236K -11,000 -14%
State Board of Administration of Florida Retirement System
59
State Board of Administration of Florida Retirement System
Florida
$1.49M – – –
TA
60
Teachers Advisors
New York
$1.43M +$75.7K +3,531 +6%
JP Morgan Chase
61
JP Morgan Chase
New York
$1.39M +$1.29M +60,001 +2,186%
VRS
62
Virginia Retirement Systems
Virginia
$1.34M +$1.3M +60,600 New
ProShare Advisors
63
ProShare Advisors
Maryland
$1.29M -$277K -12,907 -18%
TCM
64
Tekla Capital Management
Massachusetts
$1.26M – – –
Invesco
65
Invesco
Georgia
$1.18M +$747K +34,846 +188%
BBA
66
Baker Bros. Advisors
New York
$1.11M -$643K -30,000 -38%
Capital Fund Management (CFM)
67
Capital Fund Management (CFM)
France
$1.09M +$1.05M +48,979 New
Creative Planning
68
Creative Planning
Kansas
$1.06M +$735K +34,250 +249%
DekaBank Deutsche Girozentrale
69
DekaBank Deutsche Girozentrale
Germany
$1.06M +$1.04M +48,400 New
VIA
70
Vident Investment Advisory
Georgia
$1.05M +$169K +7,896 +20%
GAMA
71
Graticule Asia Macro Advisors
New York
$909K +$444K +20,700 +102%
PPA
72
Parametric Portfolio Associates
Washington
$884K +$401K +18,713 +89%
Bank of America
73
Bank of America
North Carolina
$870K -$300K -13,970 -26%
Stifel Financial
74
Stifel Financial
Missouri
$855K +$440K +20,525 +112%
BG
75
Bellevue Group
Switzerland
$821K – – –
1 2
3
4 5

JUNO Hedge Fund Activity: Q1 2017 in Review

157 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Juno Therapeutics, Inc. (JUNO) for Q1 2017, worth a combined $1.55B — up 22% from $1.27B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new JUNO positions and 26 closed out — a net gain of 3 holders — while 52 added to existing stakes and 48 trimmed.

The largest buyer was BlackRock, adding an estimated $89.5M. The largest seller was Scopia Capital Management, exiting entirely with an estimated $33.5M sold.

  • 157 institutional investors held Juno Therapeutics, Inc. (JUNO) as of Q1 2017, down from 159 in Q4 2016.
  • Funds reported $1.55B of Juno Therapeutics, Inc. stock for Q1 2017, up 22% quarter-over-quarter.
  • 29 funds opened new Juno Therapeutics, Inc. positions in Q1 2017 and 26 closed out, a net change of +3 holders.
  • The largest Juno Therapeutics, Inc. buyer in Q1 2017 was BlackRock, an estimated $89.5M added.
  • The largest Juno Therapeutics, Inc. seller in Q1 2017 was Scopia Capital Management, an estimated $33.5M sold.

Based on aggregated 13F filings for Q1 2017.